Ellen M. Janssen
Cited by
Cited by
Using best–worst scaling to investigate preferences in health care
KL Cheung, BFM Wijnen, IL Hollin, EM Janssen, JF Bridges, SMAA Evers, ...
Pharmacoeconomics 34, 1195-1209, 2016
Review of the evidence: prevalence of medical conditions in the United States population with serious mental illness
EM Janssen, EE McGinty, ST Azrin, D Juliano-Bult, GL Daumit
General hospital psychiatry 37 (3), 199-222, 2015
Improving the quality of discrete-choice experiments in health: how can we assess validity and reliability?
EM Janssen, DA Marshall, AB Hauber, JFP Bridges
Expert review of pharmacoeconomics & outcomes research 17 (6), 531-542, 2017
A framework for instrument development of a choice experiment: an application to type 2 diabetes
EM Janssen, JB Segal, JFP Bridges
The Patient-Patient-Centered Outcomes Research 9, 465-479, 2016
Assessing rationality in discrete choice experiments in health: an investigation into the use of dominance tests
T Tervonen, T Schmidt-Ott, K Marsh, JFP Bridges, M Quaife, E Janssen
Value in Health 21 (10), 1192-1197, 2018
Conducting a discrete-choice experiment study following recommendations for good research practices: an application for eliciting patient preferences for diabetes treatments
EM Janssen, AB Hauber, JFP Bridges
Value in Health 21 (1), 59-68, 2018
Analysis of patient preferences in lung cancer–estimating acceptable tradeoffs between treatment benefit and side effects
EM Janssen, SM Dy, AS Meara, PJ Kneuertz, CJ Presley, JFP Bridges
Patient preference and adherence, 927-937, 2020
Older adults’ preferences for discussing long-term life expectancy: results from a national survey
NL Schoenborn, EM Janssen, C Boyd, JFP Bridges, AC Wolff, QL Xue, ...
The Annals of Family Medicine 16 (6), 530-537, 2018
Clinical characteristics and burden of illness in patients with hereditary angioedema: findings from a multinational patient survey
J Mendivil, R Murphy, M de la Cruz, E Janssen, HB Boysen, G Jain, ...
Orphanet journal of rare diseases 16, 1-13, 2021
Preferred clinician communication about stopping cancer screening among older US adults: results from a national survey
NL Schoenborn, EM Janssen, CM Boyd, JFP Bridges, AC Wolff, ...
JAMA oncology 4 (8), 1126-1128, 2018
The evolving role of patient preference studies in health-care decision-making, from clinical drug development to clinical care management
Y Jackson, E Janssen, R Fischer, K Beaverson, J Loftus, K Betteridge, ...
Expert Review of Pharmacoeconomics & Outcomes Research 19 (4), 383-396, 2019
Education and patient preferences for treating type 2 diabetes: a stratified discrete-choice experiment
EM Janssen, DR Longo, JK Bardsley, JFP Bridges
Patient preference and adherence, 1729-1736, 2017
Caregiver treatment preferences for children with a new versus existing attention-deficit/hyperactivity disorder diagnosis
S DosReis, A Park, X Ng, E Frosch, G Reeves, C Cunningham, ...
Journal of child and adolescent psychopharmacology 27 (3), 234-242, 2017
Engaging patients and caregivers in prioritizing symptoms impacting quality of life for Duchenne and Becker muscular dystrophy
IL Hollin, H Peay, R Fischer, EM Janssen, JFP Bridges
Quality of Life Research 27, 2261-2273, 2018
Demographic, health, and attitudinal factors predictive of cancer screening decisions in older adults
NL Schoenborn, QL Xue, CE Pollack, EM Janssen, JFP Bridges, AC Wolff, ...
Preventive medicine reports 13, 244-248, 2019
AcroVoice: eliciting the patients’ perspective on acromegaly disease activity
Y Jackson, E Flood, S Rhoten, EM Janssen, M Lundie
Pituitary 22, 62-69, 2019
Identifying and prioritizing concerns associated with prosthetic devices for use in a benefit-risk assessment: a mixed-methods approach
EM Janssen, HL Benz, JH Tsai, JFP Bridges
Expert review of medical devices 15 (5), 385-398, 2018
Exploring variation in parental worries about HPV vaccination: a latent-class analysis
MB Gilkey, D Mohan, EM Janssen, AL McRee, ML Kornides, JFP Bridges
Human Vaccines & Immunotherapeutics, 2019
How do members of the Duchenne and Becker muscular dystrophy community perceive a discrete-choice experiment incorporating uncertain treatment benefit? An application of …
JFP Bridges, JH Tsai, E Janssen, NL Crossnohere, R Fischer, H Peay
The Patient-Patient-Centered Outcomes Research 12, 247-257, 2019
A cost analysis of implementing a behavioral weight loss intervention in community mental health settings: Results from the ACHIEVE trial
EM Janssen, GJ Jerome, AT Dalcin, JV Gennusa III, S Goldsholl, KD Frick, ...
Obesity 25 (6), 1006-1013, 2017
The system can't perform the operation now. Try again later.
Articles 1–20